Luteolin as an adjuvant effectively enhances CTL anti-tumor response in B16F10 mouse model

Title
Luteolin as an adjuvant effectively enhances CTL anti-tumor response in B16F10 mouse model
Authors
Keywords
Luteolin, Tumor vaccine, Adjuvant, Anti-tumor, Melanoma
Journal
INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 94, Issue -, Pages 107441
Publisher
Elsevier BV
Online
2021-02-21
DOI
10.1016/j.intimp.2021.107441

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now